A new survey from the UK’s Office of National Statistics has found that general awareness of e-cigs is high among the British population, but there is a significant number of smokers who refuse to consider even trying an e-cig.
A Swedish supreme court has made e-cigarettes legal consumer products by rejecting the country’s requirement for pharmaceutical licensing.
A medically licensed e-cigarette could make it impossible to enact voluntary or regulatory bans in the UK. But first BAT’s Nicoventures needs to produce one.
Public-health authorities should monitor e-cigarette firms on social media more closely to prevent non-vapers being tempted into trying nicotine products, new research claims.
A new proposal from public vaping in Wales would only set prohibitions in place for certain specific areas – instead of the blanket tobacco-equivalent ban originally proposed.
More vapour-related bills were introduced during the 2015 state legislative sessions than ever before, and ECigIntelligence expects even more vapour regulation to be proposed during the 2016 regular session. This report looks at the current regulatory situation across the U.S. in key areas such as manufacturing, labelling, advertising and marketing, public place usage, youth access and taxation, and forecasts the regulatory trends for 2016.
The latest in a series of regular reports from ECigIntelligence on the progress of vapour-related regulation in the U.S, focusing on the current sessions of state legislatures.
TV ads seen by young people may lead them to start vaping later, researchers claim in a report which is likely to add further fuel to the debate over e-cigarette marketing – a debate where studies that detect an influence are garnering much more attention than those that suggest advertising is less effectual.
The latest in a series of regular reports from ECigIntelligence on the progress of vapour-related regulation in the U.S, focusing on the current sessions of state legislatures.
Germany is to ban menthol e-liquid as well as many other flavours when it transposes the EU’s Tobacco Products Directive (TPD).
The furore over Sara Kalkhoran and Stanton Glantz’s meta-analysis of e-cigarettes and smoking cessation illustrates some pitfalls in conducting, and interpreting, science. ECigIntelligence takes an in-depth look at the principles and problems behind the statistics.
The first in a series of regular reports from ECigIntelligence on the progress of vapour-related regulation in the U.S, focusing on the current sessions of state legislatures.
Introduction • Regulatory landscape • Current national regulatory framework • National regulatory framework post-TPD • Age restrictions • Product restrictions • Ingredients • Labelling and packaging • Product notification • Annual reporting • Vigilance • Retailing • Public usage • North Rhine-Westphalia • Bavaria • Baden-Württemberg • Lower Saxony • Hesse • Public usage: an inconsistent future? • Advertising and marketing • Taxation • Enforcement • Case law: e-cigarettes as medical products • Case law: e-cigarettes as tobacco products • Case law: tobacco advertising restrictions • The missing pieces from the TPD jigsaw • Graphic: how German e-cigarette regulation will change
A list of terms used to describe e-cigarettes and related products by U.S. legislatures
Members of sexual minorities are far more likely than others to use e-cigarettes, according to a new U.S. study which also suggests that vaping is most popular among younger, less-educated, and lower-income groups.
As the advertising spend of U.S. e-cigarette suppliers escalates, they are continuing to use themes such as independence, rebellion and sex to sell their products – and their advertisements are prompting interest among the many young people who see them, according to a critical report from the Centers for Disease Control and Prevention (CDC). Yet some of the data relied upon by the CDC appears to raise questions of accuracy and relevance.
The U.S. House of Representatives on Monday gave final legislative approval to a bipartisan bill requiring child-resistant packaging on liquid nicotine sold in the U.S., paving the way for it to become law shortly.
The shape of future e-cigarette regulation in the UK became clearer today with the release of the government’s response to one major public consultation, and the launch of another on the issue of fees.
Medical licensing of an e-cigarette seems to have been decisive in swinging the favour of Britain’s pharmacists toward vaping.
The largest health board in Scotland has reversed a decision to ban e-cigarette use on hospital property.
The lessons taught by a computer model of anti-smoking policies could also indicate the likely effects of anti-vaping measures.
The Gulf state of Oman has become the latest in the region to ban the sale of e-cigarettes.
The Welsh Labour party has backed down on a proposal to enact a wide-ranging ban on vaping in public spaces. However, it would still like to see some areas marked as off-limits to vapers.
Are big tobacco companies starting to favour heat-not-burn technology over e-cigarettes? While none has shown any signs of overtly stepping away from e-cigs, and such a move is unlikely, much enthusiasm and investment within the tobacco industry seems to be going toward heat-not-burn.
More evidence from the U.S. backs up the e-cigarette industry’s contention that non-smokers rarely take up vaping, and also suggests that recent quitters are the most frequent users.
Most underage vapers in America prefer the taste of mint, clove, fruit, chocolate, or alcohol to plain nicotine juice. More than 80 per cent of the 1,450 teenage respondents who had experimented with e-cigs said that their first ever puff was flavoured. The only products more likely to be flavoured when teens first tried them were hookahs (88.7%), according to » Continue Reading.
It sounds like common sense: if people smoke fewer conventional cigarettes because they are using e-cigs as well, you would expect them to be exposed to fewer harmful substances. And that’s what a study has found after examining the effects on a group of smokers who were trying to quit by using e-cigs, although other research suggests that it may » Continue Reading.
Justifications for public vaping bans largely revolve around re-normalisation of conventional smoking as well as the possible health impact of secondhand vaping.
Professor Linda Bauld, an expert in public health policy, has criticised a number of articles reporting on evidence she gave to the devolved governments of Scotland saying they completely misrepresent her position.
Hungary’s transposition of the EU Tobacco Products Directive will do away with the current mandatory pharmaceutical licensing requirement for e-cigarettes – which has resulted in no nicotine-containing products being legal in the country – and allow them to be sold as consumer products. As this great change approaches, our in-depth report on Hungary includes: Regulatory landscape • Current national regulatory framework • Age restrictions • Packaging and product restrictions • Notification requirements • Retailing restrictions (including cross-border and distance sales) • Public usage • Advertising and marketing restrictions • Taxation • Case law • Enforcement • The missing pieces of the TPD jigsaw • Graphic: how Hungarian e-cigarette regulation will change
Executive summary • Introduction • Why an electronic nicotine delivery system (ENDS) product requires a PMTA: distinction among ENDS products, components/parts, and accessories; three pathways to market approval; concerns about the grandfather date • Guidance for industry: information on premarket tobacco product applications (PMTA) and the submission process • Public health considerations: scientific evidence, comparative analysis, voluntary restrictions on sale and distribution, nicotine exposure warnings, child-resistant packaging, alternatives to new scientific studies, government-sponsored databases, non-U.S. randomised controlled clinical trials, literature reviews or reports • FDA enforcement for manufacturers and retailers: enforcement limited to finished tobacco products; independent vapour shops considered as tobacco product manufacturers • Appendix 1: definitions • Appendix 2: submitting a PMTA
Regulators, health professionals and scientists are expected to converge in London this week for an update on research into vaping.
The first convincing evidence of a causal link between under-age vaping and tobacco use has delivered a shock to those who favour banning sales to minors: e-cigarettes may actually reduce teen smoking.
Contents1 Introduction2 Regulatory landscape3 Devolved administrations4 National regulatory framework5 Near-future situation in devolved administrations6 Product categorisation7 Information requirements8 Additional obligations in UK devolved countries9 Retail channels (cross-border sales)10 Age restrictions11 Devolved administrations12 Product and packaging restrictions13 Labelling and information requirements14 Public usage15 Advertising and marketing restrictions16 Devolved administrations17 Case law18 Taxation19 Enforcement There may be more recent ECigIntelligence reports » Continue Reading.
Contents1 Section 1 – Relevant consumer and safety laws2 Section 2 – BCAP/CAP rules and ASA’s enforcement3 Section 3 – Relevant medical organisations’ position towards e-cigs4 Section 4 – Politics and e-cigs in Britain and the British nations5 Section 5 – Summary of consultation questions6 Section 6 – Information sought by the regulator in the UK consultation process There » Continue Reading.
One in eight adult Americans has tried an e-cigarette, according to the federal government’s Centers for Disease Control and Prevention (CDC), though only 3.7% are still using them.
A team of tobacco control scholars has come under fire for omitting an important finding on e-cigarettes from the abstract of their latest scientific paper.
A French government agency found significant irregularities in tested e-liquid samples and e-cigarette chargers.
As the U.S. e-cig industry and policy-makers alike await the final version of the Food and Drug Administration’s deeming regulations, two conferences will be held in the Washington area next week to discuss a spectrum of issues related to tobacco and nicotine policies.
Regulators should set a standard methodology for the pharmacokinetic tests that measure how much nicotine is in vapers’ or smokers’ blood, say scientists at British American Tobacco (BAT).
A new Welsh survey has found little use of e-cigarettes among consumers who have never smoked. But is the evidence enough to prevent a proposed public vaping ban from coming into force?
Introduction • Regulatory landscape • Current national regulatory framework • National regulatory framework post-TPD • Age restrictions • Product restrictions • Ingredients • Labelling and packaging • Product notification • Annual reporting • Vigilance • Retailing • Public usage • North Rhine-Westphalia • Bavaria • Baden-Württemberg • Lower Saxony • Hesse • Public usage: an inconsistent future? • Advertising and marketing • Taxation • Enforcement • Case law: e-cigarettes as medical products • Case law: e-cigarettes as tobacco products • Case law: tobacco advertising restrictions • The missing pieces from the TPD jigsaw • Graphic: how German e-cigarette regulation will change
Experienced users should not be dismissed as unreliable sources of insight when e-cigarettes are being discussed, and their advice can be valuable for those just starting to vape or considering it, according to a British researcher.
The number and strength of chemicals absorbed in the blood of e-cigarette users is dramatically lower than in those who smoke tobacco, according to a new test of exhaled breath.
Looking like a regular cigarette is an advantage for e-cig products aiming to poach users away from tobacco, new research suggests.
A new study carried out in Hawaii is said to be the first “to attempt to elucidate the contexts of e-cigarette and cigarette use among dual users”, examining issues ranging from consumption patterns to motivations.
Two of vaping’s most eminent scientific advocates have called for bespoke regulatory regimes that follow neither the tobacco nor the pharmaceutical model, but they acknowledge that formulating appropriate rules can be a “very challenging process”.
While some critics fear that exposure to e-cigarettes and e-cig advertising among young people can lead to them taking up nicotine, a new study in Scotland suggests that awareness doesn’t always mean action.
An American public health organisation has declared that there is insufficient evidence to approve e-cigarettes as aids for smoking cessation.
The U.S. Food and Drug Administration (FDA) is this week proposing a new rule that will make it clearer when tobacco products should be considered as drugs or medical devices, and regulated accordingly.